Synthetic peptide corresponding to a region within N terminal amino acids 1-50 (MNYCMPEVHE VCPAASSNCY MQVTDYLAYL EDSPALSGRD VQAVPSSSIY) of Mouse Thyroid Hormone (NP_033406; UniProt ID: P10828 isoform 2).
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Use 10 µg for 100 µg of chromatin.
Use a concentration of 1 µg/ml. Predicted molecular weight: 2, 54 kDa. Good results were obtained when blocked with 5% non-fat dry milk in 0.05% PBS-T.
High affinity receptor for triiodothyronine.
Involvement in disease
Defects in THRB are the cause of generalized thyroid hormone resistance (GTHR) [MIM:188570, 274300]. GTHR is transmitted as an autosomal dominant trait, but an autosomal recessive form also exists. The disease is characterized by goiter, abnormal mental functions, increased susceptibility to infections, abnormal growth and bone maturation, tachycardia and deafness. Affected individuals may also have attention deficit-hyperactivity disorders (ADHD) and language difficulties. GTHR patients also have high levels of circulating thyroid hormones (T3-T4), with normal or slightly elevated thyroid stimulating hormone (TSH). Defects in THRB are the cause of selective pituitary thyroid hormone resistance (PRTH) [MIM:145650]; also known as familial hyperthyroidism due to inappropriate thyrotropin secretion. PRTH is a variant form of thyroid hormone resistance and is characterized by clinical hyperthyroidism, with elevated free thyroid hormones, but inappropriately normal serum TSH. Unlike GRTH, where the syndrome usually segregates with a dominant allele, the mode of inheritance in PRTH has not been established.
Belongs to the nuclear hormone receptor family. NR1 subfamily. Contains 1 nuclear receptor DNA-binding domain.
Composed of three domains: a modulating N-terminal domain, a DNA-binding domain and a C-terminal ligand-binding domain.